Breast Cancer News

Follow-up results from the ATEMPT trial showed that trastuzumab emtansine remained effective years after treatment in a subset of breast cancer patients, according to data presented at San Antonio Breast Cancer Symposium.

Cancer mortality in the United States has declined by 33% since 1991, according to an American Cancer Society report released today.

It’s not often that a 2 a.m. phone call marks the highlight of someone’s career.

Among women eligible for Denmark’s national breast cancer screening program, those who had an intellectual disability were less likely to undergo recommended screening, according to findings published in JAMA Network Open.

Response rates to investigational therapies evaluated in NCI-sponsored phase 1 trials for solid cancers have doubled over the past 2 decades, according to study results published in The Lancet.

Linda H. Malkas, PhD, remembers the day a photograph for a newspaper changed her life.

Among patients with breast cancer in China, those who underwent adjuvant endocrine therapy had more prevalent and more severe menopausal symptoms, according to data published in Menopause.

As precision medicine and tumor genomic testing play increasingly important roles in cancer treatment, the challenge of matching patients with appropriate cancer clinical trials has become more daunting.

A restrictive opioid prescription protocol of 3 days or less after hospital discharge appeared feasible among a cohort of patients who underwent surgery at a large cancer center, according to study results published in JAMA Oncology.

Despite being the second most prevalent histologic subtype of invasive breast cancer in the U.S., invasive lobular carcinoma is often detected later and yields worse outcomes than invasive ductal carcinoma, the most common invasive subtype.